Mandate

Vinge advises Oberthur Technologies in public offer for XPonCard

February 27, 2008

Vinge is advising Oberthur Technologies in connection with its announced public offer for XPonCard Group AB (publ). The offer, which comprises all shares in XPonCard, values XPonCard at approximately SEK 704 million.

The Vinge team advising Oberthur Technologies S.A. includes Anders Åberg, Jan Lombach, Mattias Friberg and Petter Elmstedt. Paula Röttorp, Louise Salomon and Anders Morén are providing advice regarding the financing, and Mattias Schömer and Johan Bocander are providing tax advice. Emma Dufva is providing competition law advice.

Oberthur Technologies is listed on Euronext Paris. Oberthur Technologies is one of the world leaders in the field of secure technologies in its main target markets: smart cards, secure printing and cash protection. XPonCard is a services company listed on OMX Nordic Exchange Stockholm that provides card concepts and solutions for secure payment, smart mobile solutions, improved customer loyalty and secure identification. The combination of Oberthur Technologies and XPonCard will create the second largest player in the global smart card industry with sales in the order of EUR 735 million (SEK 6.8 billion).

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026